Share Twitter LinkedIn Facebook Email Sundar Jagannath, MD of Icahn School of Medicine at Mount Sinai explains how personalized medicine will impact the treatment of multiple myeloma at the 2017 Annual Meeting Annual Meeting in Chicago, IL. Advertisement
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read
Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD Acute Lymphoblastic Leukemia 4 Mins Read